A Transcriptional Repressor Co-regulatory Network Governing Androgen Response in Prostate Cancers
Overview
Molecular Biology
Authors
Affiliations
Transcriptional corepressors are frequently aberrantly over-expressed in prostate cancers. However, their crosstalk with the Androgen receptor (AR), a key player in prostate cancer development, is unclear. Using ChIP-Seq, we generated extensive global binding maps of AR, ERG, and commonly over-expressed transcriptional corepressors including HDAC1, HDAC2, HDAC3, and EZH2 in prostate cancer cells. Surprisingly, our results revealed that ERG, HDACs, and EZH2 are directly involved in androgen-regulated transcription and wired into an AR centric transcriptional network via a spectrum of distal enhancers and/or proximal promoters. Moreover, we showed that similar to ERG, these corepressors function to mediate repression of AR-induced transcription including cytoskeletal genes that promote epithelial differentiation and inhibit metastasis. Specifically, we demonstrated that the direct suppression of Vinculin expression by ERG, EZH2, and HDACs leads to enhanced invasiveness of prostate cancer cells. Taken together, our results highlight a novel mechanism by which, ERG working together with oncogenic corepressors including HDACs and the polycomb protein, EZH2, could impede epithelial differentiation and contribute to prostate cancer progression, through directly modulating the transcriptional output of AR.
SNP rs9364554 Modulates Androgen Receptor Binding and Drug Response in Prostate Cancer.
Yan Y, Shi L, Ma T, Wang L, Huang H Biomolecules. 2025; 15(1).
PMID: 39858458 PMC: 11763896. DOI: 10.3390/biom15010064.
Chen X, Augello M, Liu D, Lin K, Hakansson A, Sjostrom M Nat Commun. 2024; 15(1):10675.
PMID: 39672812 PMC: 11645413. DOI: 10.1038/s41467-024-53734-z.
Osteoblast-Derived ECM1 Promotes Anti-Androgen Resistance in Bone Metastatic Prostate Cancer.
Wang X, Wang M, Lin Q, He L, Zhang B, Chen X Adv Sci (Weinh). 2024; 12(2):e2407662.
PMID: 39563492 PMC: 11727142. DOI: 10.1002/advs.202407662.
Cacciatore A, Shinde D, Musumeci C, Sandrini G, Guarrera L, Albino D Nat Commun. 2024; 15(1):6672.
PMID: 39107274 PMC: 11303763. DOI: 10.1038/s41467-024-50908-7.
Lu B, Liu Y, Yao Y, Yang T, Zhang H, Yang X Front Oncol. 2024; 14:1355551.
PMID: 38800374 PMC: 11116611. DOI: 10.3389/fonc.2024.1355551.